Patent · US Active

Using adiponectin receptor agonists to treat inflammation and bone diseases in diabetes

US12391646B2 · kind B2 · utility

0Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 21, 2024
Grant dateAug 19, 2025
Priority date—
Expiry dateMay 21, 2044

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are adiponectin receptor agonists and methods of using the same for the treatment of inflammation or bone loss in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.